kt-5720 and beraprost

kt-5720 has been researched along with beraprost* in 3 studies

Other Studies

3 other study(ies) available for kt-5720 and beraprost

ArticleYear
Antithrombin inhibits lipopolysaccharide-induced tumor necrosis factor-alpha production by monocytes in vitro through inhibition of Egr-1 expression.
    Journal of thrombosis and haemostasis : JTH, 2008, Volume: 6, Issue:3

    Antithrombin (AT) improves the outcome of septic patients with intravascular coagulation. However, the mechanisms underlying the therapeutic benefits of AT are not fully understood. Tumor necrosis factor-alpha (TNF-alpha) plays a critical role in the development of organ failure and intravascular coagulation in sepsis.. This study aimed to elucidate a molecular mechanism by which AT inhibits TNF-alpha production.. Human peripheral monocyte was stimulated by lipopolysaccharide (LPS) and TNF-alpha concentration in media was measured. Levels of phosphorylation of extracellular signal-regulated protein kinases (ERK) 1/2 and early growth response factor-1 (Egr-1) were estimated by western blotting or by electrophoretic mobility shift assay.. Antithrombin (3 U mL(-1)) inhibited TNF-alpha production by monocytes stimulated with LPS. Conversely, chemically modified AT that lacks affinity for heparin did not. AT inhibited the phosphorylation of ERK 1/2 and decreased the expression of Egr-1 in LPS-stimulated monocytes. However, it did not affect the activation of either nuclear factor-kappaB or activator protein-1. Pretreatment with KT5720, a protein kinase A inhibitor, reversed the inhibitory effect of AT on the LPS-induced phosphorylation of ERK1/2. Although 2 U mL(-1) AT slightly inhibited TNF-alpha production by LPS-stimulated monocytes, it significantly inhibited TNF-alpha production in the presence of a low concentration of beraprost, a stable derivative of prostacyclin.. These observations suggest that AT might inhibit LPS-induced production of TNF-alpha by inhibiting the increase in Egr-1 expression in monocytes via interaction with heparin-like substances expressed on the cell surface.

    Topics: Antithrombins; Carbazoles; Cell Survival; Early Growth Response Protein 1; Epoprostenol; Extracellular Signal-Regulated MAP Kinases; Heparin; Humans; Indoles; Lipopolysaccharides; Models, Biological; Monocytes; Phosphorylation; Platelet Aggregation Inhibitors; Pyrroles; Tumor Necrosis Factor-alpha

2008
Prostacyclin analogs stimulate VEGF production from human lung fibroblasts in culture.
    American journal of physiology. Lung cellular and molecular physiology, 2008, Volume: 294, Issue:6

    Prostacyclin is a short-lived metabolite of arachidonic acid that is produced by several cells in the lung and prominently by endothelial cells. It increases intracellular cAMP levels activating downstream signaling thus regulating vascular mesenchymal cell functions. The alveolar wall contains a rich capillary network as well as a population of mesenchymal cells, i.e., fibroblasts. The current study evaluated the hypothesis that prostacyclin may mediate signaling between endothelial and mesenchymal cells in the alveolar wall by assessing the ability of prostacyclin analogs to modulate fibroblast release of VEGF. To accomplish this study, human lung fibroblasts were cultured in routine culture on plastic support and in three-dimensional collagen gels with or without three prostacyclin analogs, carbaprostacyclin, iloprost, and beraprost, and the production of VEGF was evaluated by ELISA and quantitative real-time PCR. Iloprost and beraprost significantly stimulated VEGF mRNA levels and protein release in a concentration-dependent manner. These effects were blocked by the adenylate cyclase inhibitor SQ-22536 and by the protein kinase A (PKA) inhibitor KT-5720 and were reproduced by a direct PKA activator but not by an activator of exchange protein directly activated by cAMP (Epac), indicating that cAMP-activated PKA signaling mediated the effect. Since VEGF serves to maintain the pulmonary microvasculature, the current study suggests that prostacyclin is part of a bidirectional signaling network between the mesenchymal and vascular cells of the alveolar wall. Prostacyclin analogs, therefore, have the potential to modulate the maintenance of the pulmonary microcirculation by driving the production of VEGF from lung fibroblasts.

    Topics: Adenine; Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Adult; Carbazoles; Cell Culture Techniques; Cells, Cultured; Epoprostenol; Fibroblasts; Humans; Iloprost; Lung; Prostaglandins I; Pyrroles; RNA, Messenger; Stimulation, Chemical; Vascular Endothelial Growth Factor A

2008
Cyclic AMP inhibits stretch-induced overexpression of fibronectin in glomerular mesangial cells.
    European journal of pharmacology, 2002, Feb-22, Volume: 437, Issue:3

    Glomerular hypertension is proposed to play an important role in the progression of various glomerular diseases. Glomerular mesangial cells are considered to be exposed to the stretch stress due to glomerular hypertension and are found to produce the excess amount of extracellular matrix (ECM) proteins including fibronectin when exposed to the mechanical stretch. Herein, we provide the evidence that cAMP-generating agents inhibit the stretch-induced overexpression of fibronectin through the inhibition of the stretch-induced activation of mitogen-activated protein kinases (MAPKs) in protein kinase-A-dependent manner. We also found that the mechanical stretch enhanced the binding of nuclear extracts to activator protein-1 (AP-1)-like sequences in the promoter region of rat fibronectin gene and this enhancement was also prevented by the cAMP-generating agent. These results indicate that the agents, which activate cAMP/protein kinase-A axis, may work protectively against the injury from glomerular hypertension in mesangial cells.

    Topics: Animals; Blotting, Northern; Blotting, Western; Bucladesine; Carbazoles; Cyclic AMP; Enzyme Activation; Enzyme Inhibitors; Epoprostenol; Fibronectins; Gene Expression Regulation; Glomerular Mesangium; Indoles; Male; Mitogen-Activated Protein Kinases; Nuclear Proteins; Oligonucleotides; Protein Binding; Pyrroles; Rats; Rats, Sprague-Dawley; RNA, Messenger; Stress, Mechanical; Transcription Factor AP-1

2002